Comparison of melphalan‐ And busulfan‐based myeloablative conditioning in children undergoing allogeneic transplantation for acute myeloid leukemia or myelodysplasia-Reference-Cited by-同舟云学术

Comparison of melphalan‐ And busulfan‐based myeloablative conditioning in children undergoing allogeneic transplantation for acute myeloid leukemia or myelodysplasia

Published:2020-02-18 Issue:4 Volume:24 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Oshrine Benjamin¹^ORCID,Adams Lauren¹,Nguyen Anh Thy H.¹,Amankwah Ernest¹,Shyr David²,Hale Gregory¹,Petrovic Aleksandra³

Affiliation:

1. Johns Hopkins All Children's Hospital Saint Petersburg Florida

2. Lucile Packard Children's Hospital Palo Alto CA USA

3. Seattle Children's Hospital Seattle WA USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13672

Reference14 articles.

1. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation

2. Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

3. Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

4. Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis

5. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia;Journal of Clinical Medicine;2021-08-25

2. Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis;Hematology;2021-01-01

3. Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients;Clinical Pharmacokinetics;2020-10-30